Search
-
News
Neratinib, which targets mutations that drive cancer growth, is showing promise for treating several types of cancer.
… Sunday, April 2, 2017 Summary Neratinib, an experimental drug developed to target certain mutations that drive cancer growth, is showing promise for treating several types of cancer. The findings from a phase II study were presented at the 2017 AACR Annual Meeting . Highlights Basket trials are based
-
-
Department of Medical Physics
… I am an attending physicist in the Department of Medical Physics. My clinical research explores ways to improve how we deliver radiation treatment to MSK patients. When we use the most precise methods possible, we kill cancer cells while keeping nearby healthy tissue safe. My research is about using
-
News
New findings could lead to a different kind of cancer drug that targets a DNA damage repair pathway called nucleotide excision repair.
… Monday, January 11, 2021 Summary A study has uncovered new findings about a DNA repair pathway called nucleotide excision repair and its role in the development of cancer. The paper also details how this defective pathway could be targeted with drugs. Memorial Sloan Kettering scientists have discovered
-
News
Learn more about DeepHeme, an artificial intelligence tool that helps doctors to diagnose blood and bone marrow cancers.
… Wednesday, June 11, 2025 Researchers at Memorial Sloan Kettering Cancer Center (MSK), the University of California, San Francisco (UCSF), and University of California, Berkeley (UC Berkeley) have developed an artificial intelligence (AI) tool called DeepHeme that can help automate the diagnosis of blood
-
Learn about the common signs and symptoms of brain metastases.
… The symptoms and signs of brain metastases can be hard to see at first. We often find these tumors when we are testing you for other health conditions. We also find them when we are assessing the stage of your primary cancer. Your symptoms usually depend on the tumor’s location and size. Possible symptoms
-
Biotherapeutics
… Job Title Technical Writing Specialist Email [email protected] Lab Phone 646-888-3671
-
Technology Development
… Description SK-RC-17 is a metastatic renal cancer cell line derived from the soft tissue of the abdominal wall which grows in nude mice. This is cell line is part of a collection of renal cell carcinoma (RCC) cell lines derived from metastatic sites of patients who underwent surgery. Source This cell
-
The Ming Li Lab
Scientist, Genentech
… Job Title Scientist, Genentech Fellowships GSK Grayer Fellowship (2020-2021) Olayan Fellowship (2019-2020) Education BS, The Chinese University of Hong Kong; Cancer Biology Degree PhD Dissertation Cooperative Control of Peripheral T Helper Cell Tolerance by TGF-B Signaling in Helper T-Cells Mentor The
-
Department of Medicine at MSK
… Job Title Assistant Attending Physicist I am an assistant attending physicist in the Department of Medical Physics at Memorial Sloan Kettering Westchester. Working closely with radiation oncologists, dosimetrists, and radiation therapists, I am responsible for delivering precise patient radiotherapy